ClinicalTrials.gg
RecruitingNCT07094282PAINUpdated Aug 21, 2026

Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)

An interventional study of Acupuncture and myofascial therapy in Chronic Pain, sponsored by David Moss. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by David Moss · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
125
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,283 studies in Chronic Pain with a site in United States — 257 open to participants now, 348 under way, 7 of them phase 3. Chronic Pain · United States.

Planned enrollment
312th of 1,092
125 · median 60
Started
2025
with 91 others
No phase
803 of 1,283
168 open now
Primary completion
2028-07
later than 281 of 347 live
Registered
1,181st of 1,283
by date

Among the 1,283 studies in Chronic Pain with a site in United States, this one is the 312th largest by planned enrollment of the 1,092 interventional ones that give a count, is one of 92 that started in 2025, is one of 803 with no phase, reaches primary completion later than 281 of the 347 other live ones, and was the 1,181st registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

257 of the 1,283 studies in Chronic Pain with a site in United States are open now. Recruiting first, the newest first:

252 more — sign in →

All 257 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,283 studies in Chronic Pain with a site in United States, or all of them as a file.
02

Study summary

With vast numbers of active-duty members restricted from their specific duties or deemed unfit for deployment because of low back pain, both the mission of the Department of Defense and overall military workflow can be significantly impacted. More than restriction from duty or being barred from deployment, studies have shown musculoskeletal conditions were among the top reasons for medical disability retirement in the Army and Marine Corps (Niebuhr; Sikorski). Given the significant time, money, and resources invested in training these members, each day of inactivity or disability detrimentally affects the execution of the military's mission. Therefore, precise diagnosis and effective treatment modalities are paramount to foster healing and reduce recovery time.

From an operational standpoint, the United States Department of Defense (DoD) is specifically interested in using tailored integrative medicine modalities to manage chronic conditions encountered in the military health system. Not just chronic pain, but polytrauma and the triad of conditions it encompasses; traumatic brain injury and post-traumatic stress disorder combined with chronic pain (Madsen, Kim, Bedard). The DoD's goal is also to decrease opioid prescribing and the addiction and altered state associated with opioids.

AT the Nellis Integrative Medicine Clinic, physicians, a chiropractor, and nurses are engaged in the treatment of patients. All personnel are trained in the various modalities available in the clinics.

A variety of modalities are utilized in the clinic. This prospective study will evaluate the effectiveness of the many modalities used in the Integrative Medicine Clinic (such as acupuncture, myofascial therapies, microcurrent therapies, LASER therapy, extracorporeal shockwave therapy, and pulsed electromagnetic therapies).

Most patients receive treatments using multiple modalities. DoD goals align with our experiences in the Integrative Medicine Clinic at Mike O'Callaghan Military Medical Center. Many servicemembers and dependents in our clinic are trying to avoid surgery, or their pain medications - opioid or not - are no longer working. Additionally, many patients are trying to avoid Do Not Fly status caused by pharmacologic approaches. Patient experiences at our IMC also correlate with a study where 80% of people surveyed felt integrative medicine should be routinely offered at all MTFs (Ross). While our patients generally are not on opioids, we have anecdotally noted a reduction or cessation of opioids in several patients. The impacts of such a reduction in opioid usage for military readiness is clear (Madsen).

Read the detailed description

All of the below items are research-related unless marked as 'standard of care'. Visits will vary depending on provider-decided treatments and will generally range from 30 minutes to 2 hours in length.

Self-reported pain intensity assessment.

Screening visit (1 hour):

  • Obtain and document signed Informed Consent document and HIPAA Authorization
  • Verify subject eligibility based on inclusion/exclusion criteria. Medical record will verify inclusion.
  • -Record all medications including over the counter the subject is taking. Record morphine milligram equivalents (MME) for patients taking opioid medications. Collect basic demographic information to include phone number, email address, DoD ID, age, race, ethnicity, assigned sex at birth, weight (pounds), height (inches), and BMI, estimated annual income.
  • Collect additional information to include:

    • Beneficiary Status (Active-Duty, Retired Active-Duty, dependent, Reservist)
    • rank (if applicable),
    • employment status and description (full time, part time, unemployed, retired, homemaker) number of deployments (if applicable), Marital status (Married, Domestic Partners, Divorced, Widow/er, separated, single/never married)
    • education (military training; high school/GED; some college; 2 year college; 4 year college; some graduate work; completed master's or professional degree; completed Ph.D., law degree, MD, similar advanced professional degree)
  • Patient History, was there a precipitating injury, location of pain (neck, thoracic, or lumbar), history of surgery and type of surgery, any history of pain management interventions (injections, ablations, etc) especially related to the subject's chronic axial spine pain
  • Other therapies for their condition currently receiving or in the last 3 months (ie chiropractic, physical therapy, pain management etc) Randomization: Subjects will not be randomized as this is a single armed cohort study. Subjects will be assigned a unique study code in sequential order beginning with 001.

SURVEY RELATED VISITS

Visit 1 (week 0 can be the same day as screening visit) (30 minutes) (In-person or Virtual):

BASELINE

  • Subject will fill out the following Standard of Care Patient Questionnaires:
  • PROMIS Physical Function Form 6b
  • 6 questions evaluating physical function
  • DVPRS 0-10 Scale
  • pain assessment tool using numerical rating scale enhances by functional word descriptors, color coding, and pictorial facial expressions
  • PEG
  • Assesses pain intensity and interference
  • Patient Health Questionnaire 2-item (PHQ-2)
  • Measures depressed mood and anhedonia over past 2 weeks
  • Survey is extended to a 9-item PHQ-9 only for subjects scoring 3 or higher on the PHQ-2
  • Generalized Anxiety Disorder 2-item (GAD-2)
  • Screening tool for generalized anxiety disorder
  • Survey is extended to a 7-item GAD-7 only for subjects scoring 3 or higher on the GAD-2
  • Pain Catastrophizing Scale
  • Quantifies pain experience (rumination, magnification, and helplessness)
  • Pittsburgh Sleep Quality Index
  • Dallas Pain Questionnaire
  • 16 item quality of life questionnaire assessing multiple domains
  • Patient receives treatment preferably same day, but within 72 hours
  • Scores may be pulled from patient Electronic Medical Record

Visit 2 (Week 4) (60 minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Scores may be pulled from patient Electronic Medical Record

Visit 3 (Week 8) (60 Minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Scores may be pulled from patient Electronic Medical Record

Visit 4 (Week 12) (60 Minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Patient receives treatment at provider discretion
  • Scores may be pulled from patient Electronic Medical Record

Visit 5 (Week 16) (60 minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Scores may be pulled from patient Electronic Medical Record

Visit 6 (Week 20) (60 minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Scores may be pulled from patient Electronic Medical Record

Visit 7 (Week 24) (60 minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Scores may be pulled from patient Electronic Medical Record

Visit 8 (Week 28) (60 minutes) (In-person or Virtual) Research coordinator with record morphine milligram equivalents (MME) for patients taking opioid medications.

  • Subject will complete the following Standard of Care Patient Questionnaires:
  • PEG
  • PHQ-2 or PHQ-9 (PHQ-2 score > 2)
  • GAD-2 or GAD-7 (GAD-2 score > 2)
  • Pain Catastrophizing Scale
  • Pittsburgh Sleep Quality Index
  • DVPRS 0-10 Scale
  • PROMIS Physical Function Form 6b
  • Dallas Pain Questionnaire
  • Scores may be pulled from patient Electronic Medical Record
  • Treatment Helpfulness Questionnaire
  • Active duty members will be asked if duty, fitness or mobility restrictions were lifted during the study period

TREATMENT VISITS Treatments given in Integrative Medicine Clinic will be at provider discretion. Subjects will attend a minimum of 3 visits then additional treatment sessions will be at provider discretion as well.

The following semi structured clinical algorithm will be used by providers in the clinic.

Visit 1:

  1. Initial interview with focus on whole person
  2. Microcurrent standard protocols (Standard concussion protocol, Spinal Cord long)
  3. Myofascial work to include transverse abdominus teaching, rectus abdominus release, other myofascial, time permitting or as needed
  4. Optional Loan of microcurrent box with protocols at physician discretion
  5. Optional loan of avazzia or alpha stim at physician discretion
  6. Home Exercise Program handout (Rx3)

    Visit 2:

  7. Assess effect of prior myofascial work
  8. Re-education of TA activation, additional myofascial work as needed (including lower trap and

    /or glut med activation)

  9. Assess effect of Microcurrent
  10. Optional Loan of microcurrent box with protocols at physician discretion
  11. Optional loan of avazzia or alpha stim at physician discretion
  12. create plan for visit 3 (this could include additional myofascial work, shock wave therapy, acupuncture/dry needling, avazzia or alpha stim)

    Visits 3 through final:

  13. Continue treatment with any or all of the following modalities

a. Myofascial treatments (functional neuromyofascial techniques [FNT], cupping, gua sha, active needling) b. Frequency Specific Microcurrent (FSM) c. Avazzia d. Extracorporeal shock wave therapy (ESWT) e. Acupuncture/dry needling f. Alpha stim (cranio-electric stimulation) Coordinators will monitor subject visits either in-person post each visit or by accessing the EMR post each visit to record visit details. Visit Details to Record

  • Visit Number (1-10, >10)
  • ICD-10 codes
  • Examples
  • M54.2 Cervicalgia
  • M54.5 Low Back Pain
  • M79.7 Fibromyalgia
  • Z73.3 PTSD*
  • M54.9 Dorsalgia, unspecified
  • F41.9 Anxiety
  • M25.51 Shoulder Pain
  • M54.6 Thoracic Spinal Pain
  • M72.2 Plantar Fasciitis
  • L90.5 Scar Conditions and Fibrosis of Skin
  • Modalities Used
  • Examples
  • Myofascial modalities (FNT, cupping, scraping/gua sha, active needling)
  • FSM
  • Avazzia
  • Acupuncture
  • Dry needling
  • Alpha Stim
  • ESWT
03

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • integrative medicine
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

**Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study**

Inclusion criteria

Inclusion Criteria:

  • Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 or older referred to the Nellis Integrative Medicine Clinic chronic back or neck pain
  • Pain Chronicity Threshold (pain score ≥4/10 documented in EMR or reported by patient at least 2 times in one year and at least 30 days apart).

Exclusion criteria

Exclusion Criteria:

  • Enrolled in other pain management program (e.g. pain management, PT

    /OT)

  • Anticipated Change of station, deployment, retirement from military service, separation from active or reserve military service (includes national guard) or plan to discontinue enrollment at MOMMC in \<6 months
  • Planned surgery during the study period
  • Pregnancy
  • \<3 months post-partum
  • Hypermobility disorders such as Ehlers Danlos
  • Active cancer (cancer in remission is not an exclusion)
  • Implanted electrical devices that cannot be turned off (ie pacemaker); implanted stimulators or pumps that can be turned off are not exclusionary
  • Injury or surgery within the last 6 weeks
  • Dementia
  • Delirium
  • Inability to make medical decisions or understand treatment plan as decided upon by principle or associate investigators
  • Undergoing medical evaluation board
  • Currently in the process of establishing or appealing VA disability rating, or planning to do so within the study period
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
125 participants (estimated)

Study arms

  • Experimental
    Integrative Medicine (pre to post treatment)

    Patients will act as their own control with preintervention scores. The main integrative medicine intervention therapies include but may not be limited to acupuncture, myofascial therapies, microcurrent therapies, LASER therapy, extracorporeal shockwave therapy, and pulsed electromagnetic therapies.

    Other: Acupuncture · Other: myofascial therapy · Other: microcurrent therapy · Other: LASER · Other: extracorporeal shockwave therapy · Other: Pulsed electromagnetic therapies · Other: Miscellaneous integrative medicine

Interventions

  • OtherAcupuncture

    Integrative Medicine: Acupuncture treatment

  • Othermyofascial therapy

    Integrative Medicine: myofascial therapy to include transverse abdominus teaching, rectus abdominus release, functional neuromyofascial techniques, cupping, gua sha, active needling.

  • Othermicrocurrent therapy

    Integrative Medicine: Microcurrent

  • OtherLASER

    Integrative Medicine: LASER

  • Otherextracorporeal shockwave therapy

    Integrative Medicine: Extracorporeal shockwave therapy

  • OtherPulsed electromagnetic therapies

    Integrative Medicine: Pulsed electromagnetic therapies

  • OtherMiscellaneous integrative medicine

    other integrative medicine modalities

06

What researchers measure

Primary outcomes

  1. Dallas Pain Questionnaire

    16 item quality of life questionnaire assessing multiple domains

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  2. PROMIS physical function form 6b

    6 questions evaluating physical function

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  3. Defense and Veterans Pain Rating Scale

    pain assessment tool using numerical rating scale enhanced by functional word descriptors, color coding, and pictorial facial expressions

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  4. PEG (pain average, enjoyment of life, and general activity)

    assesses pain intensity and interference

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  5. Patient Health Questionnaire 2-item (PHQ-2)

    measures depressed mood and anhedonia over past 2 weeks

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  6. Patient health questionnaire 9-item

    measures more detailed depressed mood and anhedonia if patient scores 3 or higher on phq-2

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  7. Generalized Anxiety Disorder 2-item

    screening tool for generalized anxiety disorder

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  8. Generalized Anxiety Disorder 7-item

    extended screening tool for generalized anxiety disorder to use if subjects score 3 or higher on GAD-2

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  9. Pain Catastrophizing Scale

    quantifies pain experience (rumination, magnification, and helplessness)

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

  10. Pittsburgh Sleep Quality Index

    Self-report questionnaire that assesses sleep quality over a one-month time interval. The global score ranges from 0 to 21. Higher scores indicate poorer sleep quality.

    Time frame: baseline (pre-treatment) through study period (visit 1, week 0) (visit 2, week 4) (visit 3, week 8) (visit 4, week 12) (visit 5, week 16) (visit 6, week 20) (visit 4, week 24) (visit 8, week 28)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Demographic and clinical data will be acquired from 125 participants. All data will be de-identified prior to receipt by the repository, but the information needed to generate a global unique identifier for the NLM Data Archive (NDA) (clinicaltrials.gov) will be collected for each subject. Sufficient data from this project will be preserved to enable sharing via NDA data of sufficient quality to validate and replicate research findings described in the Aims. NLM requires data measured from human subjects to be shared using the NDA. Demographic data, clinical data, data collection tools and study protocols will be made available in the NDA.

Supporting information: Study protocol, Informed consent form

Time frame: All data will be deposited to clinicaltrials.gov starting 12 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates.

Access criteria: Data will be findable for the research community through the NDA Collection that will be established when this application is funded. For all publications, an NDA study will be created. Each of those studies is assigned a digital object identifier (DOI). This data DOI will be referenced in the publication to allow the research community easy access to the exact data used in the publication. The research community will have access to data when the award ends. As required by NDA, studies will also be created that contain the data used for every publication. Those studies will be shared when the pre-print is available. NDA studies have digital object identifiers (DOI) to aid in findability. We will include that DOI in relevant publications. NDA will make decisions about how long to preserve the data, but that data archive has not deleted any deposited data up to now.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Jul 2028, 35 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 35 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2025
First posted
Jul 30, 2025
StartActual
Aug 4, 2025
Primary completionEst.
Jul 2028
CompletionEst.
Jul 2028
Last update
Aug 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07094282
Lead sponsor
David Moss
Responsible party
David Moss (Principal Investigator/Doctor, Mike O'Callaghan Military Hospital) — Sponsor-investigator
First posted
Jul 30, 2025
Start date
Aug 4, 2025
Primary completion
Jul 2028 (estimated)
Completion
Jul 2028 (estimated)
Last update
Aug 21, 2026

Study contacts

Daniel Shaffer, BSBA
Contact
daniel.w.shaffer.civ@health.mil
702-653-2067

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion